Effectiveness of Recombinant Desulphatohirudin in Reducing Restenosis After Balloon Angioplasty of Atherosclerotic Femoral Arteries in Rabbits

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Circulation

• Publication date

  1991-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.84.1.232PMID 1829399
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thrombin

  2019cited by this paper
• Effect of lovastatin on intimal hyperplasia after balloon angioplasty: a study in an atherosclerotic hypercholesterolemic rabbit.

  1991cited by this paper
• Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition.

  1990cited by this paper
• Vascular reactivity after balloon angioplasty in an atherosclerotic rabbit.

  1990cited by this paper
• Hirudin, heparin, and placebo during deep arterial injury in the pig. The in vivo role of thrombin in platelet-mediated thrombosis.

  1990cited by this paper
• The effects of thrombin on bovine aortic endothelial and smooth muscle cells.

  1990cited by this paper
• Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury.

  1989cited by this paper
• Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor.

  1989cited by this paper
• Morphometric analysis of the composition of atherosclerotic plaques in the four major epicardial coronary arteries in acute myocardial infarction and in sudden coronary death.

  1989cited by this paper
• Restenosis After Coronary Angioplasty: Potential Biologic Determinants and Role of Intimal Hyperplasia

  1989cited by this paper
• Influence of inflation pressure and balloon size on the development of intimal hyperplasia after balloon angioplasty. A study in the atherosclerotic rabbit.

  1989cited by this paper
• Thrombin causes increased monocytic-cell adhesion to endothelial cells through a protein kinase C-dependent pathway.

  1989cited by this paper
• Recombinant Desulphatohirudin (CGP 39393) Anticoagulant and Antithrombotic Properties In Vivo

  1989cited by this paper
• Effects of percutaneous transluminal coronary angioplasty on atherosclerotic plaques and relation of plaque composition and arterial size to outcome.

  1988cited by this paper
• Sequence of cellular responses in rabbit aortas following one and two injuries with a balloon catheter.

  1988cited by this paper
• Platelet accumulation in experimental angioplasty: time course and relation to vascular injury.

  1987cited by this paper
• Restenosis after arterial angioplasty: a hemorrheologic response to injury.

  1987cited by this paper
• Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty.

  1987cited by this paper
• Thrombin Interactions with Cultured Fibroblasts: Relationship to Mitogenic Stimulation a

  1986cited by this paper
• Platelet activation by alpha-thrombin is a receptor-mediated event.

  1986cited by this paper
• Restenosis after successful coronary angioplasty in patients with single-vessel disease.

  1986cited by this paper
• Platelet Activation by α‐Thrombin Is a Receptor‐Mediated Event a

  1986cited by this paper
• The biology of platelet-derived growth factor

  1986cited by this paper
• Deep arterial injury during experimental angioplasty: relation to a positive indium-111-labeled platelet scintigram, quantitative platelet deposition and mural thrombosis.

  1986cited by this paper
• Thrombin‐Cellular Interactions

  1986cited by this paper
• Pharmacology of hirudin: one hundred years after the first report of the anticoagulant agent in medicinal leeches.

  1985cited by this paper
• Clinical and angiographic assessment 6 months after double vessel percutaneous coronary angioplasty.

  1985cited by this paper
• Interaction of platelets with the vessel wall

  1985cited by this paper
• Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute.

  1984cited by this paper
• Localization of a chemotactic domain in human thrombin.

  1984cited by this paper
• Balloon angioplasty in multivessel coronary artery disease.

  1983cited by this paper
• Balloon angioplasty in multivessel coronary artery disease.

  1983cited by this paper
• Acute Effects of Transluminal Angioplasty in Three Experimental Models of Atherosclerosis

  1982cited by this paper
• Percutaneous transluminal coronary angioplasty: report from the Registry of the National Heart, Lung, and Blood Institute.

  1982cited by this paper
• Comparison of Degree and Extent of Coronary Narrowing by Atherosclerotic Plaque in Anterior and Posterior Transmural Acute Myocardial Infarction

  1981cited by this paper
• New rabbit atherosclerosis model for the investigation of transluminal angioplasty.

  1981cited by this paper
• Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty.

  1979cited by this paper
• Purification of human platelet-derived growth factor.

  1979cited by this paper
• Control of proliferation of human vascular endothelial cells. Characterization of the response of human umbilical vein endothelial cells to fibroblast growth factor, epidermal growth factor, and thrombin

  1978cited by this paper
• Conditions which affect initiation of animal cell division by trypsin and thrombin

  1978cited by this paper
• Cell surface action of thrombin is sufficient to initiate division of chick cells.

  1978cited by this paper
• Experimental atherosclerosis in rabbits fed cholesterol-free diets. 5. Comparison of peanut, corn, butter, and coconut oils.

  1976cited by this paper
• Mitogenic activity of blood components. I. Thrombin and prothrombin.

  1975cited by this paper
• Significance of fixation procedure for preservation of arteries

  1972cited by this paper
• [69] Hirudin as an inhibitor of thrombin

  1970cited by this paper
• THE STRUCTURE OF HAEMOSTATIC PLUGS AND EXPERIMENTAL THROMBI IN SMALL ARTERIES.

  1964cited by this paper
• Demonstration of all connective tissue elements in a single section; pentachrome stains.

  1955cited by this paper

• The quest for effective pharmacological suppression of neointimal hyperplasia.

  2020cites this paper
• Role of thrombin in the pathogenesis of atherosclerosis

  2018cites this paper
• Novel Direct Anticoagulants and Atherosclerosis.

  2018cites this paper
• Bolus injections of novel thrombogenic site-targeted fusion proteins comprising annexin-V and Kunitz protease inhibitors attenuate intimal hyperplasia after balloon angioplasty.

  2017cites this paper
• EXPERIMENTAL STUDIES Reduced Acute Thrombus Formation Results in Decreased Neointimal Proliferation After Coronary Angioplasty

  2016cites this paper
• Assessment of Novel Anti-thrombotic Fusion Proteins for Inhibition of Stenosis in a Porcine Model of Arteriovenous Graft

  2015cites this paper
• The role of tissue factor pathway inhibitor in atherosclerosis and arterial thrombosis.

  2013cites this paper
• Pharmacological Approaches to the Prevention of Restenosis Following Angioplasty

  2012cites this paper
• Stent implantation in the superficial femoral artery: short thrombelastometry-derived coagulation times identify patients with late in-stent restenosis.

  2012cites this paper
• Pharmacological Approaches to the Prevention of Restenosis Following Angioplasty

  2012cites this paper
• Bivalirudin utilization in cardiac surgery: shifting anticoagulation from indirect to direct thrombin inhibition

  2011cites this paper
• Effects of antithrombin III treatment in vascular injury model of mice

  2011cites this paper
• The polyamine pathway as a potential target for vascular diseases: focus on restenosis.

  2011cites this paper
• Unchecked thrombin is bad news for troubled arteries.

  2007cites this paper
• STUDIES ON DRUG ELUTING STENTS IN PREVENTION OF RENAL ARTERY STENOSIS IN DOGS

  2007influential citation
• In vitro-in vivo correlations of drug release for biodegradable polymer stent.

  2007cites this paper
• Role of thrombin in coronary artery bypass grafting

  2007cites this paper
• Melagatran Reduces Advanced Atherosclerotic Lesion Size and May Promote Plaque Stability in Apolipoprotein E– Deficient Mice

  2006cites this paper
• Postinjury vascular intimal hyperplasia in mice is completely inhibited by CD34+ bone marrow‐derived progenitor cells expressing membrane‐tethered anticoagulant fusion proteins

  2006cites this paper
• Length-Sensing Function of Troponin C and Starling ' s Law of the Heart

  2005cites this paper
• Heparin , Arterial Injury , and Drug Delivery 1221 in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids

  2005cites this paper
• Direct thrombin inhibitors are not equally effective in vivo against arterial thrombosis: in vivo evaluation of DuP714 and argatroban in a porcine angioplasty model and comparison to r-hirudin.

  2005cites this paper
• Femoral Artery Restenosis After Balloon Angioplast in Hypercholesterolemic Rabbits

  2005cites this paper
• Comment Thrombin and Other Potential Mechanisms Underlying Restenosis

  2005cites this paper
• Heparin , Arterial Injury , and Drug Delivery 1221 in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids

  2005cites this paper
• Current Perspectives Direct Thrombin Inhibitors in Cardiovascular Medicine

  2005cites this paper
• Heparin , Arterial Injury , and Drug Delivery 1221 in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids

  2005cites this paper
• Heparin , Arterial Injury , and Drug Delivery 1221 in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids

  2005cites this paper
• Thrombin‐induced glucose transport via Src–p38 MAPK pathway in vascular smooth muscle cells

  2005cites this paper
• Heparin , Arterial Injury , and Drug Delivery 1221 in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids

  2005cites this paper
• Unintended consequences in a quickly evolving world

  2005cites this paper
• Mechanisms of thrombosis and restenosis after vascular injury

  2005cites this paper
• The effect of anticoagulation with subcutaneously delivered polyethylene glycol conjugated hirudin and recombinant tissue plasminogen activator on recurrent stenosis in the rabbit double-balloon injury model.

  2004cites this paper
• Current status of catheter- and stent-based gene therapy.

  2004cites this paper
• Local delivery of argatroban for the prevention of restenosis after coronary balloon angioplasty: a prospective randomized pilot study.

  2004cites this paper
• [Prospective randomized study of argatroban versus heparin anticoagulation therapy after percutaneous coronary intervention for acute myocardial infarction].

  2004cites this paper
• Local drug delivery in restenosis injury: thermoresponsive co-polymers as potential drug delivery systems.

  2004cites this paper
• Klinik der koronaren Herzerkrankung III: Der Herzinfarkt im chronischen Stadium

  2004cites this paper
• Inhibition of neointimal hyperplasia by a specific thrombin inhibitor

  2004cites this paper
• The Effects of Platelet-Derived Growth Factor Inhibitor(Trapidil) on Intimal Hyperplasia Following Coronary Stenting: Assessed by Intravascular Ultrasound

  2003cites this paper
• Prolonged procoagulant activity on overstretch‐injured coronary arteries in pigs

  2003cites this paper
• Melagatran attenuates fibrin and platelet deposition in a porcine coronary aartery over‐stretch injury model

  2003cites this paper
• Gene Transfer and Functional Expression in Mammalian Cells of the Medicinal Leech Anti-coagulant Hirudin Using Adeno-Associated Virus Vectors

  2003cites this paper
• Hirulog-like peptide reduces restenosis and expression of tissue factor and transforming growth factor-beta in carotid artery of atherosclerotic rabbits.

  2003cites this paper
• Carotid Artery Ligation Model Plasminogen Activator Inhibitor 1 and Vitronectin Protect Against Stenosis in a Murine

  2002cites this paper
• The Effects of (66)Ho-Loaded Radioactive Stent in a Porcine Model

  2002cites this paper
• &bgr;-Cyclodextrin tetradecasulfate, a novel cyclic oligosaccharide, inhibits thrombus and neointimal formation after coronary vascular injury

  2002cites this paper
• Pharmacology and Clinical Use of Bivalirudin

  2002cites this paper
• Tissue factor pathway inhibitor gene delivery using HVJ-AVE liposomes markedly reduces restenosis in atherosclerotic arteries.

  2002cites this paper
• Plasminogen Activator Inhibitor 1 and Vitronectin Protect Against Stenosis in a Murine Carotid Artery Ligation Model

  2002cites this paper
• Aurintricarboxylic Acid Attenuates Intimal Thickening after Balloon Injury of the Rabbit Aorta

  2002cites this paper
• Treating atherosclerosis: local drug delivery from laboratory studies to clinical trials.

  2002cites this paper
• Activation mechanisms in vascular disease

  2002cites this paper
• Systemically administered thrombin inhibitors can prevent neointimal formation and cerebral vasospasm: The possible role of thrombin and PDGF-BB in vascular pathogeneses

  2002cites this paper
• New tricks for old dogs: nonthrombotic effects of thrombin in vessel wall biology.

  2001cites this paper
• Overview of therapies for prevention of restenosis after coronary interventions.

  2001cites this paper
• Thrombolytic therapy for acute myocardial infarction

  2001cites this paper
• Comparative trial of local pharmacotherapy with L-arginine, r-hirudin, and molsidomine to reduce restenosis after balloon angioplasty of stenotic rabbit iliac arteries.

  2001cites this paper
• Coagulation cascade proteases and tissue fibrosis.

  2001cites this paper
• CHAPTER 54 – Coronary Atherosclerosis and Restenosis

  2001cites this paper
• Thrombin activates p38 mitogen-activated protein kinase in vascular smooth muscle cells.

  2001cites this paper
• A COMPARISON OF HIRUDIN WITH HEPARIN IN THE PREVENTION OF RESTENOSIS AFTER CORONARY ANGIOPLASTY P

  2001cites this paper
• Thrombin‐induced p38 mitogen‐activated protein kinase activation is mediated by epidermal growth factor receptor transactivation pathway

  2001cites this paper
• Selective alpha(v)beta(3)-receptor blockade reduces macrophage infiltration and restenosis after balloon angioplasty in the atherosclerotic rabbit.

  2001cites this paper
• Tissue factor as a therapeutic target in coronary syndromes.

  2001cites this paper
• Local gene transfer of tissue factor pathway inhibitor regulates intimal hyperplasia in atherosclerotic arteries

  2001cites this paper
• A Peptide Analogue of Thrombin Receptor–Activating Peptide Inhibits Thrombin and Thrombin-Receptor-Activating Peptide–Induced Vascular Smooth Muscle Cell Proliferation

  2001cites this paper
• There is no effect on remodeling of vascular wall 4 weeks after local delivery of antithrombin in a porcine model of coronary overstretching

  2001cites this paper
• A Four-Hour Infusion of Recombinant Hirudin Results in Long-Term Inhibition of Arterial-Type Thrombosis in Baboons

  2000cites this paper
• Inhibition of arterial thrombosis by a peptide ligand of the thrombin receptor.

  2000cites this paper
• Hirudin reduces tissue factor expression and attenuates graft arteriosclerosis in rat cardiac allografts.

  2000cites this paper
• Induction of IG9 monocyte adhesion molecule expression in smooth muscle and endothelial cells after balloon arterial injury in cholesterol-fed rabbits.

  2000cites this paper
• Induction of IG 9 Monocyte Adhesion Molecule Expression in Smooth Muscle and Endothelial Cells After Balloon Arterial Injury in Cholesterol-Fed Rabbits

  2000cites this paper
• All-trans-retinoic acid limits restenosis after balloon angioplasty in the focally atherosclerotic rabbit : a favorable effect on vessel remodeling.

  2000cites this paper
• Endothelial Cells After Balloon Arterial Injury in Cholesterol-Fed Rabbits Induction of IG 9 Monocyte Adhesion Molecule Expression in Smooth Muscle and

  2000cites this paper
• Inhibition of tissue factor reduces thrombus formation and intimal hyperplasia after porcine coronary angioplasty.

  2000cites this paper
• Suppression of arterial intimal hyperplasia by cilostamide, a cyclic nucleotide phosphodiesterase 3 inhibitor, in a rat balloon double‐injury model

  2000cites this paper
• Heparinas de Bajo Peso Molecular en la Cardiopatía Isquémica Metabólica. Bases Moleculares: Experiencia Clínica y Resultados

  2000cites this paper
• Role of clot‐associated (‐derived) thrombin in cell proliferation induced by fibrin clots in vitro

  2000cites this paper
• The Effects of Local Delivery of Paclitaxel Nanoparticle on Porcine Coronary Stent Restenosis

  2000cites this paper
• Smooth muscle cell outgrowth stimulated by fibrin degradation products. The potential role of fibrin fragment E in restenosis and atherogenesis.

  2000cites this paper
• Inhibition of neointima formation after experimental coronary artery stenting: a new biodegradable stent coating releasing hirudin and the prostacyclin analogue iloprost.

  2000cites this paper
• Procoagulant activity during coronary interventions and coronary artery patency.

  1999cites this paper
• The Utility of Animal Models in the Preclinical Study of Interventions to Prevent Human Coronary Artery Restenosis: Analysis and Recommendations

  1999cites this paper
• Targeting endogenous platelet-derived growth factor B-chain by adenovirus-mediated gene transfer potently inhibits in vivo smooth muscle proliferation after arterial injury

  1999cites this paper
• Gbetagamma‐Mediated Signaling: New Therapeutic Target for Proliferative Vascular Disease

  1999cites this paper
• Synergy between thrombin and serotonin in inducing vascular smooth muscle cell proliferation.

  1999cites this paper
• Systemic Thrombin Inhibition by Hirulog Does Not Alter Medial Smooth Muscle Cell Proliferation and Inflammatory Activation after Vascular Injury in the Rabbit

  1999cites this paper
• Inhibitors of Tissue Factor/Factor VIIa

  1999cites this paper
• Atherosclerotic Rabbit : A Favorable Effect on Vessel Remodeling-Retinoic Acid Limits Restenosis After Balloon Angioplasty in the Focally trans

  1999cites this paper
• Local Adenovirus-Mediated Delivery of Hirudin in a Rabbit Arterial Injury Model

  1999cites this paper
• The Effects of the Heparin-Coated Maximum Arterial Re-Creation (MAC) Stent on Porcine Coronary Stent Restenosis

  1999cites this paper
• Treatment of unstable angina: the role of platelet inhibitors and anticoagulants.

  1999cites this paper
• Syndromes of Accelerated Atherosclerosis

  1999cites this paper
• Retroviral vector-mediated expression of hirudin by human vascular endothelial cells: implications for the design of retroviral vectors expressing biologically active proteins

  1999cites this paper
• Parenteral direct antithrombins

  1999cites this paper
• Tissue factor pathway inhibitor attenuates procoagulant activity and upregulation of tissue factor at the site of balloon-induced arterial injury in pigs.

  1999cites this paper
• Coronary angioplasty: an end to early closing?

  1999cites this paper
• Structural requirements for TFPI-mediated inhibition of neointimal thickening after balloon injury in the rat.

  1999cites this paper
• The significance of platelet-derived growth factors for proliferation of vascular smooth muscle cells.

  1999cites this paper